How much? Pfiz­er leads top phar­ma com­pa­nies' ramped up lob­by spend­ing on Con­gress

K Street saw an­oth­er record year in 2021 for lob­by­ing ex­pen­di­tures, and some of the biggest bio­phar­ma com­pa­nies in the world shelled out mil­lions to sway Con­gress, re­veal­ing some of their key pri­or­i­ties along the way.

Pfiz­er topped the list of the largest phar­ma com­pa­nies in the lat­est quar­ter, spend­ing near­ly $3 mil­lion on lob­by­ing in Q4, which is about half a mil­lion more than they spent in the same quar­ter a year ear­li­er, but not quite as high as its Q1 2020 lev­el of more than $4 mil­lion. In 2021, Pfiz­er spent more than $10.3 mil­lion, about half a mil­lion less than in 2020.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.